Chemoinformaics analysis of 3,7-Dimethyloctane-1,7-diol 3,7-Dimethyloctane-1,7-diol
| Molecular Weight | 174.284 | nRot | 6 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 14 |
| Exact Molecular Weight | 174.162 | nRing | 0 |
| Solubility: LogS | -5 | nHRing | 0 |
| Solubility: LogP | 4.676 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 32.9734 |
| nHD | 2 | BPOL | 22.0706 |
| QED | 0.549 |
| Synth | 4.189 |
| Natural Product Likeliness | 2.805 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.52 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.524 |
| MDCK | 0.0000201 |
| BBB | 0.91 |
| PPB | 0.858461 |
| VDSS | 1.536 |
| FU | 0.164844 |
| CYP1A2-inh | 0.321 |
| CYP1A2-sub | 0.107 |
| CYP2c19-inh | 0.254 |
| CYP2c19-sub | 0.712 |
| CYP2c9-inh | 0.281 |
| CYP2c9-sub | 0.611 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.677 |
| CYP3a4-inh | 0.143 |
| CYP3a4-sub | 0.274 |
| CL | 5.25 |
| T12 | 0.113 |
| hERG | 0.004 |
| Ames | 0.017 |
| ROA | 0.021 |
| SkinSen | 0.093 |
| Carcinogencity | 0.934 |
| EI | 0.109 |
| Respiratory | 0.463 |
| NR-Aromatase | 0.023 |
| Antiviral | No |
| Prediction | 0.82989 |